Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from Pharmacorp Rx Inc. ( (TSE:PCRX) ) is now available.
PharmaCorp Rx Inc. has successfully closed a C$23 million bought deal public offering, co-led by several financial partners. The proceeds will be used for future acquisitions and general working capital. The offering included the issuance of common shares and warrants, with conditional approval for listing the warrants on the TSX Venture Exchange. This move is part of PharmaCorp’s strategy to expand its network of community pharmacies in Canada, enhancing its market position and providing opportunities for pharmacists and retiring pharmacy owners.
More about Pharmacorp Rx Inc.
PharmaCorp Rx Inc. is a Canadian pharmacy acquisition and ownership platform focused on empowering pharmacists as equity partners and supporting succession for retiring pharmacy owners. The company is building a national network of community pharmacies under the PharmaChoice Canada banner, currently operating seven such pharmacies, and aims to acquire more across Canada.
Average Trading Volume: 64,096
Technical Sentiment Signal: Sell
Current Market Cap: C$51.73M
Find detailed analytics on PCRX stock on TipRanks’ Stock Analysis page.